Longevity & Aging · Metabolic & Cardiometabolic
periodic fasting-mimicking diet FMD cycles improves cardiometabolic biomarkers weight BP IGF-1 glucose lipids CRP in humans
In plain terms: Do a few days of a low-calorie fasting-mimicking diet each month actually improve blood-sugar, blood-pressure and cholesterol markers?
Yes, small RCTs mostly Longo's own network show modest short-term improvements, but they largely overlap with plain calorie restriction/weight loss and independent replication is thin.
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
The evidence (11)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Espinoza 2025 · GeroScience | RCT | supports | low | Pilot RCT found FMD improved fasting glucose, HOMA-IR, BHB and autophagic flux in healthy adults, though effects were not significant across all timepoints and it was industry-sponsored. |
| Sulaj 2025 · Mol Metab | RCT | supports | moderate | 6-month periodic fasting (FMD-type) regimen restored metabolic flexibility and improved albuminuria in type 2 diabetes, with accompanying metabolic improvements. |
| Kulkarni 2026 · Nat Med | RCT | mixed | moderate | RCT of monthly 5-day FMD cycles in Crohn's disease showed reduced inflammation (fecal calprotectin) and clinical response, though endpoints were disease-activity rather than classic cardiometabolic markers. |
| Andriessen 2022 · Diabetologia | RCT | mixed | moderate | Independent (Schrauwen group) crossover RCT of a related fasting protocol (TRE) in T2D: improved glucose homeostasis but did NOT improve insulin sensitivity — partial, non-FMD replication of benefit with a null on a key mechanism. |
| Siavoshi 2025 · Ann Neurol | RCT | mixed | moderate | Secondary analysis of fasting-mimicking/calorie-restriction diets reduced metabolomic age in multiple sclerosis, but daily calorie reduction had no effect, indicating benefits are protocol-dependent. |
| Brandhorst 2024 · Nat Commun | RCT | supports | low | Human secondary/exploratory analysis of Longo-lab RCTs: 3 FMD cycles lowered insulin resistance, pre-diabetes markers and hepatic fat; Longo-lab, exploratory. |
| Micarelli 2025 · Cell Rep Med | RCT | supports | moderate | Human 102-subject cross-over RCT: 6 monthly FMD cycles reduced cardiometabolic/inflammatory markers and diabetic drug use; Longo is a co-author (not fully independent). |
| Gabriel 2022 · Nutrients | observational | mixed | low | Independent single-arm water-fast+refeed study: cardiometabolic markers improved at follow-up but triglycerides/HOMA-IR transiently WORSENED at end-of-refeed — shows fasting-family benefits are real but track weight loss and have transient adverse phases. |
| Tavakoli 2025 · J Health Popul Nutr | meta-analysis | mixed | moderate | GRADE-assessed meta-analysis of fasting regimens found beneficial shifts in weight-regulating hormones but no effect on resistin and called for long-term data. |
| Schoonakker 2025 · Nutr Metab Cardiovasc Dis | RCT | supports | moderate | FMD programme alongside usual care reduced abdominal visceral fat while preserving muscle in type 2 diabetes, supporting cardiometabolic benefit. |
| Burns 2025 · Clin Nutr | RCT | supports | moderate | Randomized parallel-group 7-day FMD improved cardiometabolic markers and autophagy signals versus non-intervention control in healthy humans. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.